Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
George L Sing is Director at Regeneron Pharmaceuticals. OQRO lists 22 transactions filed with the SEC under this name, the latest on Nov 18, 2026, each linked to the official Form 4.
Director
Disclosures on record
22
Companies involved
1
As of the latest filing on , George L Sing reported holding 23,147 shares of Regeneron Pharmaceuticals (REGN), worth about $21.9M at the last close of $946 (Nov 18, 2026). In the last 12 months, George L Sing sold $22.3M in 13 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN | 23,147 | 23K direct | $946 | $21.9M | Nov 17, 2026 |
Is this George L Sing’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Regeneron PharmaceuticalsREGN
22 disclosures · Dec 2025 – Nov 2026 · 13 sold
Nov 16, 2026Sold~$960Kdisclosed Nov 18
DetailsOfficial recordNov 17, 2026Sold~$446Kdisclosed Nov 18
DetailsOfficial recordNov 17, 2026Sold~$344Kdisclosed Nov 18
DetailsOfficial recordNov 17, 2026Sold~$168Kdisclosed Nov 18
DetailsOfficial recordNov 2, 2026Sold~$6.83Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$4.18Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$2.58Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$2.43Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$1.47Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$1.18Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$1.01Mdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$519Kdisclosed Nov 4
DetailsOfficial recordNov 2, 2026Sold~$194Kdisclosed Nov 4
DetailsOfficial recordNov 2, 20267,439disclosed Nov 4
DetailsOfficial recordNov 2, 20267,830disclosed Nov 4
DetailsOfficial recordNov 2, 20267,830disclosed Nov 4
DetailsOfficial recordNov 2, 20267,439disclosed Nov 4
DetailsOfficial recordJan 2, 2026155disclosed Jan 6
DetailsOfficial recordJan 2, 20261,962disclosed Jan 6
DetailsOfficial recordDec 30, 20259,212disclosed Dec 31
DetailsOfficial recordDec 30, 20259,212disclosed Dec 31
DetailsOfficial recordDec 30, 20256,188disclosed Dec 31
DetailsOfficial recordGeorge L Sing bought shares on the open market in 2009 and 2010, and has not bought since 2010. Sales in 10 of the 18 years since 2009.
George L Sing reported 5 open-market purchases and 147 sales since 2009; purchases in 2 different years, most recently 2010.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $22.3M13×13 trades |
| 2024 | — | $5.33M8×8 trades |
| 2022 | — | $2.47M3×3 trades |
| 2021 | — | $17.8M26×26 trades |
| 2020 | — | $84.4M73×73 trades |
| 2018 | — | $5.72M5×5 trades |
| 2015 | — | $11M4×4 trades |
| 2014 | — | $9.95M4×4 trades |
| 2013 | — | $4.3M2×2 trades |
| 2012 | — | $5.85M9×9 trades |
| 2010 | $214K2×2 trades | — |
| 2009 | $235K3×3 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 17, 2026, George L Sing reported holding 23,147 shares of Regeneron Pharmaceuticals (REGN). At the last close of $946 on Nov 18, 2026, that is about $21.9M. This is the stake disclosed in filings, not a net worth.
No public filing gives George L Sing's net worth. What SEC Form 4 shows is the stock stake: 23,147 shares of Regeneron Pharmaceuticals (REGN), about $21.9M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, George L Sing reported 13 open-market sales worth $22.3M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
George L Sing bought shares on the open market in 2009 and 2010, and has not bought since 2010. Sales in 10 of the 18 years since 2009.
In SEC filings since 2009: the latest open-market purchase is from 2010; the latest open-market sale is from 2026.
Regeneron Pharmaceuticals (REGN), from 2009 to 2026: 5 purchases and 147 sales.
George L Sing reported 5 open-market purchases and 147 sales here, 2009 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.